skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 202563 Add to Shopping cart Find in a Library
Title: National Synthetic Drugs Action Plan: The Federal Government Response to Production, Trafficking, and Abuse of Synthetic Drugs and Diverted Pharmaceutical Products
Corporate Author: Office of National Drug Control Policy
United States of America
Date Published: October 2004
Page Count: 78
Sponsoring Agency: Drug Policy Information Clearinghouse
Rockville, MD 20849
NCJRS Photocopy Services
Rockville, MD 20849-6000
Office of National Drug Control Policy
Washington, DC 20500
Sale Source: NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States of America

Drug Policy Information Clearinghouse
P.O. Box 6000
Rockville, MD 20849
United States of America
Document: PDF
Type: Legislation/Policy Description
Format: Document
Language: English
Country: United States of America
Annotation: This action plan outlines the Federal Government’s response to the problem of synthetic drugs and diverted pharmaceuticals under the President’s National Drug Control Strategy.
Abstract: In recent years, the production and use of synthetic drugs has grown dramatically. The most significant synthetic drug threat is posed by MDMA and methamphetamine use. Part 1 provides an introduction to the report and identifies the Office of National Drug Control Policy and the Department of Justice as the co-chairs of the new Synthetic Drugs Interagency Working Group (SD-IWG), which will assume overarching responsibility for implementing the recommendations outlined in this report. Recommendations are then provided in the areas of prevention, treatment, regulation, and law enforcement. Part 2 offers an overview of the current consumption and trafficking trends with respect to synthetic drugs and diverted pharmaceuticals in the United States. Part 3 outlines the Federal Government’s plan of action to combat the problem of synthetic drug use and diverted pharmaceutical use. The recommended actions are grouped into the aforementioned categories of prevention, treatment, regulation, and law enforcement action. Current strategies being implemented in these areas are enumerated, followed by recommendations for future action. Recommendations include developing targeted prevention programs, increasing treatment capacity, and enhancing information exchange and coordination with Canada. Appendixes provide information about the proposed outline for an early warning and response system to address emerging drug threats; an overview of the new Drug Abuse Warning Network (DAWN) system; an action plan to prevent the diversion of OxyContin; the regulatory measures that apply to the drugs of interest in this report; and a summary of Missouri and Oklahoma precursor chemical control laws. The SD-IWG must submit a written implementation plan for the recommendations contained herein within 6 months of the publication of this action plan. Figures, appendixes, notes
Main Term(s): Drug Policy
Index Term(s): Governmental planning; MDMA (designer drug); Plans
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.